<DOC>
	<DOCNO>NCT00621413</DOCNO>
	<brief_summary>The purpose study observe PSA response incidence side effect patient diagnosed intermediate high risk prostate cancer treat Cesium-131 combination external beam therapy .</brief_summary>
	<brief_title>Observation Outcomes Side Effects Cesium-131 Combination With External Beam Radiation Treatment Intermediate High Risk Prostate Cancer</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>Histologically confirm adenocarcinoma prostate Clinical stage T1c T2c ( AJCC 6th Edition ) , NX/N0 , M0 Karnofsky Performance Score 90 100 Greater equal 18 year age Prostate volume TRUS ≤ 60 cc IPSS score &lt; 15 ( alpha blocker allow ) Signed studyspecific inform consent form prior study entry Intermediate Risk prostate cancer determine follow : Gleason sum 7 ; PSA le 10.1 ng/ml ; Stage T2a less Gleason sum 6 less ; PSA &gt; 10.0 &lt; 20.1ng/ml ; Stage T2a less Gleason sum 6 less ; PSA &lt; 10.1 ; Stage T2b High risk prostate cancer determine follow : Any Gleason Sum ; PSA great 20 ng/ml ; Stage T2c less Gleason Sum &gt; 7 ; Any PSA ; Stage T2c less Any Gleason Sum ; Any PSA ; Stage T2c Any two three intermediate risk factor Lymph node involvement ( N1 ) Evidence distant metastasis ( M1 ) Any hormonal blockade therapy : Has persist 6 month time protocol screen ; OR Is ongoing within 3 month study enrollment Radical surgery carcinoma prostate Prior pelvic radiation Previous concurrent cancer basal , situ , squamous cell skin cancer unless diseasefree ≥ 5 year Major medical psychiatric illness , investigator 's opinion , would prevent completion treatment would interfere followup Hip prosthesis Inability refusal provide inform consent</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2008</verification_date>
	<keyword>prostate</keyword>
	<keyword>cancer</keyword>
	<keyword>intermediate risk</keyword>
	<keyword>high risk</keyword>
	<keyword>brachytherapy</keyword>
	<keyword>Cesium-131</keyword>
	<keyword>seed brachytherapy</keyword>
	<keyword>intermediate high risk cancer prostate</keyword>
</DOC>